| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9175 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.6856 |
| P-glycoprotein Substrate | Non-substrate | 0.7677 |
| P-glycoprotein Inhibitor | Inhibitor | 0.5000 |
| Non-inhibitor | 0.8534 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8634 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5117 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7522 |
| CYP450 2D6 Substrate | Non-substrate | 0.8017 |
| CYP450 3A4 Substrate | Non-substrate | 0.6222 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.8831 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7352 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8905 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8094 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.5495 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6666 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8960 |
| Non-inhibitor | 0.8031 |
| AMES Toxicity | AMES toxic | 0.9744 |
| Carcinogens | Non-carcinogens | 0.8288 |
| Fish Toxicity | High FHMT | 0.8804 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9423 |
| Honey Bee Toxicity | Low HBT | 0.6661 |
| Biodegradation | Not ready biodegradable | 0.8872 |
| Acute Oral Toxicity | III | 0.7861 |
| Carcinogenicity (Three-class) | Warning | 0.5447 |